Appleby shortlisted for three awards in the ALB China Law Awards 2025
Published: 6 May 2025
Type: News
The ALB China Law Awards honor the exceptional achievements of leading law firms, private practitioners, in-house teams in China, and notable deal cases from the past year.
Appleby is shortlisted for:
- Offshore Law Firm of the Year
- Chimagen Biosciences Sells CMG1A46 Asset to GSK Chimagen Biosciences for M&A Deal of the Year – Mid Size. Appleby acted as the Cayman legal counsel to GSK Plc.
- Unisplendour’s Strategic Investment in H3C Technologies for M&A Deal of the Year – Premium. Appleby acted as the Cayman legal counsel to Unisplendour International Technology Limited
About Appleby
Appleby is an international offshore law firm. The firm leverages its expertise in M&A, restructuring, private equity, and dispute resolution to deliver tailored solutions for complex legal challenges. With ten global offices and expertise in eight jurisdictions, the firm provides seamless multi-jurisdictional advice. Appleby is consistently ranked as a leader in offshore legal services by top industry directories.
